OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
By P. Medina, M. Nolde, Frank J. Slack. Nature, 2010
993 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/cf348a0cefe0fedd7d15bf8a2b58725dbcaf5c30
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Carlo Maria Croce
- Joshua T. Mendell
- H. Horlings
- Frank J. Slack
- E. Olson
- Thomas Tuschl
- Pavel Morozov
- T. Farazi
In Molecular Biology
- Carlo Maria Croce
- Joshua T. Mendell
- H. Horlings
- E. Olson
- Thomas Tuschl
- Pavel Morozov
- T. Farazi
- Manel Esteller
Citations in the corpus
- microRNAs in cancer (2013, background): “Several strains of mice lacking or overexpressing cancer-associated miRNAs have been developed and characterized, including the germ-line transgenic or knockout mice of miR155 (39), miR-17/92 and its paralogs (60–62), miR-21 (40), miR-221 (63), the miR-15/16-1 cluster (64), miR-122 (65, 66), and miR”
- OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer (2016, positive): “It is even possible for cancers to become completely reliant upon, or "addicted", to an oncomiR, such that suppression of the oncomiR results in complete regression of the cancer (1).”
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review (2012, neutral): “More recently, Slack’s group (Medina et al, 2010) has shown that mice conditionally expressing miR-21 develop a pre-B malignant lymphoid-like phenotype, thus demonstrating that miR-21 is a genuine oncogene. miR-17-92 cluster and miR-155, both discovered to be overexpressed in lymphoproliferative…”
- Non-coding RNAs in human disease (2011, background): “A good example is a mouse model that conditionally expresses miR-21, which revealed the function of this miRNA as a genuine oncogen”
- MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy (2011, neutral): “, three groups generated mir-21 -knockout or mir-21 -overexpressing mic”
- Exosome Uptake through Clathrin-mediated Endocytosis and Macropinocytosis and Mediating miR-21 Delivery* (2014, background): “miR-21 is a unique miRNA that is overexpressed in most tumor types (31).”
- MicroRNAs in stress signaling and human disease (2012, background): “, 2006) or miR-21 (Medina et al., 2010) is sufficient to initiate lymphomagenesis in mice.”
- miRNAs in human cancer (2010, background): “Over-expression of another oncogene, mir-21, frequently highly expressed in solid and haematological malignancies, resulted in a pre-B malignant lymphoid-like phenotype, whereas subsequent mir-21 inactivation in the same model led to apoptosis and tumour regression [158].”
- MicroRNAs in human cancer. (2013, background): “Overexpression of another oncogene, miR-21, frequently highly expressed in solid and hematologic malignancies, resulted in a pre-B malignant lymphoid like phenotype whereas subsequent miR-21 inactivation in the same model led to apoptosis and tumor regression [ 174 ] .”
- Improved classification of breast cancer by analysis of genetic alterations and gene expression profiling (2011, background): “We noted the drastic up-regulation of miR-21 in carcinomas, recently identified as an oncogene in mouse models (45, 46).”